Back to top

Amphastar Pharmaceuticals (AMPH) Gets a Hold from Piper Sandler

In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Amphastar Pharmaceuticals, with a price target of $20.00....

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Amphastar Pharmaceuticals, Inc. (AMPH)